nsc 327729 has been researched along with amifostine anhydrous in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (45.45) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golden, RN; Grunbaum, Z; Krohn, KA; Livesey, JC; Shankland, EG; Wyman, M | 1 |
| Srinivasan, V; Weiss, JF | 1 |
| Franz, CG; McDonough, JH; Mele, PC | 1 |
| Chin, L; Krohn, KA; Magee, S; Nelson, N; Rasey, JS | 2 |
| Grunbaum, Z; Krohn, KA; Livesey, JC | 1 |
| Golden, RN; Grunbaum, Z; Krohn, KA; Livesey, JC; Richards, TL; Shankland, EG; Wade, RA | 1 |
| Altschuler, EM; Hunter, N; Milas, L; Murray, D | 1 |
| Chin, L; Freeman, LM; Grunbaum, Z; Krohn, KA; Livesey, JC; Magee, S; Nelson, NJ; Rasey, JS; Vertrees, S | 1 |
| Badger, CC; Krohn, KA; Livesey, JC; Rasey, JS; Spence, AM; Vera, DM | 1 |
| Edmondson, SE; Krohn, KA; Rasey, JS; Spence, AM; Steele, JE | 1 |
| Altschuler, EM; Kerr, MS; Meyn, RE; Milas, L; Murray, D; Vanankeren, SC | 1 |
| Grunbaum, Z; Krohn, KA; Menard, TW; Rasey, JS; Spence, AM; Wade, RA | 1 |
| Krohn, KA; Menard, TW; Rasey, JS; Spence, AM | 1 |
| Edmondson, SW; Grunbaum, Z; Krohn, KA; Rasey, JS; Spence, AM; Steele, JE | 1 |
| Ali-Osman, F; Chin, L; Dwyer-Hansen, L; Grunbaum, Z; Krohn, KA; Livesey, J; Nelson, N; Rasey, JS; Spence, AM; Stein, D | 1 |
| Kumar, KS; Palazzolo, DL | 1 |
| Fingar, VH; Lindberg, RD; Sigdestad, CP; Wieman, TJ | 1 |
| Kumar, S; Srinivasan, V; Weiss, JF | 1 |
| Baxter, S; Bogo, V; Clark, EP; Harris, AH; Hogan, JB; Kumar, KS; Landauer, MR; Palazzolo, D | 1 |
| Brook, I; D'Alesandro, MM; MacVittie, TJ; Patchen, ML; Solberg, BD | 1 |
| Davis, HD; Kumar, KS; Landauer, MR; Weiss, JF | 1 |
1 review(s) available for nsc 327729 and amifostine anhydrous
| Article | Year |
|---|---|
Specific protection of different normal tissues.
Topics: Amifostine; Animals; Humans; Radiation Injuries; Radiation Injuries, Experimental; Radiation-Protective Agents; Tissue Distribution | 1988 |
21 other study(ies) available for nsc 327729 and amifostine anhydrous
| Article | Year |
|---|---|
Magnetic resonance spectroscopic measurement of cellular thiol reduction-oxidation state.
Topics: Amifostine; Carbon Radioisotopes; Glutathione; Glutathione Disulfide; Indicators and Reagents; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Radiation-Protective Agents | 1992 |
Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice.
Topics: Amifostine; Animals; Injections, Subcutaneous; Male; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Survival Rate; Vitamin E | 1992 |
Comparison of behavioral and radioprotective effects of WR-2721 and WR-3689.
Topics: Amifostine; Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Milk; Radiation-Protective Agents; Rats; Rats, Inbred Strains; Reinforcement Schedule | 1992 |
Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
Topics: Amifostine; Animals; Cell Survival; Dose-Response Relationship, Radiation; Intestines; Mice; Neutrons; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1990 |
Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins.
Topics: Amifostine; Animals; Blood Proteins; Brain; Chemical Phenomena; Chemistry; Disulfides; Kidney; Liver; Lung; Magnetic Resonance Spectroscopy; Male; Organothiophosphorus Compounds; Protein Binding; Proteins; Radiation-Protective Agents; Rats; Rats, Inbred Strains | 1990 |
Measurement of tissue oxidation-reduction state with carbon-13 nuclear magnetic resonance spectroscopy.
Topics: Amifostine; Animals; Disulfides; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Oxidation-Reduction; Sulfhydryl Compounds | 1989 |
Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Topics: Amifostine; Animals; Cell Survival; DNA Damage; DNA, Neoplasm; Jejunum; Mice; Mice, Inbred C3H; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation-Protective Agents; Stem Cells | 1989 |
In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
Topics: Amifostine; In Vitro Techniques; Organothiophosphorus Compounds; Radiation-Protective Agents | 1988 |
WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cord.
Topics: Amifostine; Animals; Cesium Radioisotopes; Female; Injections, Intraventricular; Paralysis; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Inbred F344; Spinal Cord | 1988 |
Radioprotection of cultured Chinese hamster ovary cells by WR-255591.
Topics: Amifostine; Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; DNA Damage; In Vitro Techniques; Radiation-Protective Agents; Sulfhydryl Compounds | 1988 |
Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).
Topics: Amifostine; Animals; Autoradiography; Chemical Phenomena; Chemistry; Cytoplasmic Granules; Lung; Male; Mice; Mice, Inbred C3H; Organothiophosphorus Compounds; Submandibular Gland | 1986 |
Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors.
Topics: Amifostine; Animals; Mice; Neoplasms, Experimental; Radiation-Protective Agents; Tissue Distribution | 1986 |
Toxicity and biodistribution of the radioprotectors, WR2721, WR77913, and WR3689, in the CNS following intraventricular or intracisternal administration.
Topics: Amifostine; Animals; Central Nervous System; Cisterna Magna; Injections, Intraventricular; Organothiophosphorus Compounds; Radiation-Protective Agents; Rats | 1986 |
Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
Topics: Amifostine; Animals; Cell Survival; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Organothiophosphorus Compounds; Radiation-Protective Agents | 1986 |
Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates.
Topics: Amifostine; Animals; Brain; Brain Neoplasms; Female; Homocysteine; Male; Mice; Mice, Inbred C3H; Radiation-Protective Agents; Rats; Rats, Inbred F344; Spinal Cord; Tissue Distribution; Tumor Cells, Cultured | 1995 |
Effects of S-2-(3-methylaminopropylamino)ethyl phosphorothioic acid (WR-3689), alone or combined with caffeine, on catecholamine content of mouse hypothalamus.
Topics: Amifostine; Animals; Caffeine; Dopamine; Drug Interactions; Hypothalamus; Male; Mice; Norepinephrine; Radiation-Protective Agents | 1993 |
Chemical modification of normal tissue damage induced by photodynamic therapy.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Drug Hypersensitivity; Hematoporphyrin Photoradiation; Male; Mice; Mice, Inbred C3H; Radiation-Protective Agents; Skin | 1996 |
Radioprotection by misoprostol (PGE1 methyl analog) in combination with vitamin E, selenomethionine and WR-3689794.
Topics: Amifostine; Animals; Confidence Intervals; Drug Synergism; Gamma Rays; Male; Mice; Mice, Inbred Strains; Misoprostol; Pseudomonas Infections; Radiation-Protective Agents; Selenomethionine; Survival Rate; Vitamin E | 1997 |
Effects of eicosanoid radioprotectors on rat motor performance.
Topics: Amifostine; Analysis of Variance; Animals; Eicosanoids; Electric Stimulation; Iloprost; Lipid A; Male; Misoprostol; Motor Activity; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Radioprotection by polysaccharides alone and in combination with aminothiols.
Topics: Amifostine; Animals; Cell Survival; Drug Therapy, Combination; Female; Gamma Rays; Glucans; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Macrophage Activation; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Radiation-Protective Agents; Sulfhydryl Compounds; Survival Analysis; Time Factors | 1992 |
Behavioral toxicity of selected radioprotectors.
Topics: 16,16-Dimethylprostaglandin E2; Adjuvants, Immunologic; Amifostine; Animals; Caffeine; Central Nervous System Stimulants; Cord Factors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucans; Interleukin-1; Leukotriene C4; Male; Mice; Motor Activity; Phospholipids; Platelet Activating Factor; Radiation-Protective Agents; Sulfhydryl Compounds | 1992 |